PTGS2 and metabolic dysfunction-associated steatotic liver disease: The latter PUFAs can be enzymatically converted into proinflammatory eicosanoids by Cyclooxygenase-2 (COX-2), identified as markers for inflammatory processes in NAFLD and higher in HCC (Yang et al., 2011; Sztolsztener et al., 2020).